4//SEC Filing
Arnold Jonathan 4
Accession 0001596783-21-000189
CIK 0001596783other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 3:35 PM ET
Size
20.2 KB
Accession
0001596783-21-000189
Insider Transaction Report
Form 4
Catalent, Inc.CTLT
Arnold Jonathan
President, Oral Drug Delivery
Transactions
- Exercise/Conversion
Common Stock
2021-11-01$36.02/sh+1,962$70,671→ 47,046 total - Exercise/Conversion
Common Stock
2021-11-01$42.23/sh+1,039$43,877→ 48,085 total - Exercise/Conversion
Common Stock
2021-11-01$43.88/sh+2,400$105,312→ 50,485 total - Exercise/Conversion
Options to purchase Common Stock
2021-11-01−2,400→ 2,745 totalExercise: $43.88Exp: 2028-07-23→ Common Stock (2,400 underlying) - Exercise/Conversion
Common Stock
2021-11-01$54.94/sh+2,158$118,561→ 52,643 total - Sale
Common Stock
2021-11-01$140.02/sh−10,672$1,494,293→ 41,971 total - Exercise/Conversion
Options to purchase Common Stock
2021-11-01−1,962→ 0 totalExercise: $36.02Exp: 2027-07-24→ Common Stock (1,962 underlying) - Exercise/Conversion
Options to purchase Common Stock
2021-11-01−1,039→ 1,042 totalExercise: $42.23Exp: 2027-10-04→ Common Stock (1,039 underlying) - Exercise/Conversion
Options to purchase Common Stock
2021-11-01−2,158→ 4,318 totalExercise: $54.94Exp: 2029-07-22→ Common Stock (2,158 underlying)
Footnotes (8)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
- [F2]Includes restricted stock units.
- [F3]Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
- [F4]Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]On July 24, 2017, the reporting person was granted options to purchase 7,839 shares of common stock of the Issuer which vest and become exercisable in four equal annual installments beginning on July 24, 2018.
- [F6]On October 4, 2017, the reporting person was granted options to purchase 4,159 shares of common stock of the Issuer which vest and become exercisable in four equal annual installments beginning on October 4, 2018.
- [F7]The options vest and become exercisable in four equal annual installments beginning on July 23, 2019.
- [F8]The options vest and become exercisable in four equal annual installments beginning on July 22, 2020.
Documents
Issuer
Catalent, Inc.
CIK 0001596783
Entity typeother
Related Parties
1- filerCIK 0001721336
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 3:35 PM ET
- Size
- 20.2 KB